** U.S.-listed shares of Canada-based cannabis producer rise ~12 pct to $6.66 premarket
** Q2 net rev rose to C$13.4 mln from C$1.2 mln a year earlier; main contributor was addition of adult-use sales
** Co realized first full quarter since legalization in Canada
** Q2 net loss of C$4.3 mln vs C$8.9 mln a year-ago period
** Adult-use cannabis revenue, excluding excise tax, rose to C$14.8 mln from C$5.2 mln in Q1
** Up to Wednesday’s close, U.S.-listed stock has risen ~14 pct YTD
Reporting by Debroop Roy
Our Standards: The Thomson Reuters Trust Principles.